Request Demo
Last update 15 Dec 2025
BNT162b2/Recombinant Influenza Vaccine(Pfizer)
Last update 15 Dec 2025
Overview
Basic Info
Drug Type Prophylactic vaccine, mRNA vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 1234627550
The sequence is quoted from: *****
Related
1
Clinical Trials associated with BNT162b2/Recombinant Influenza Vaccine(Pfizer)NCT06237049
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older
100 Clinical Results associated with BNT162b2/Recombinant Influenza Vaccine(Pfizer)
Login to view more data
100 Translational Medicine associated with BNT162b2/Recombinant Influenza Vaccine(Pfizer)
Login to view more data
100 Patents (Medical) associated with BNT162b2/Recombinant Influenza Vaccine(Pfizer)
Login to view more data
100 Deals associated with BNT162b2/Recombinant Influenza Vaccine(Pfizer)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Phase 2 | United States | 31 Jan 2024 | |
| Influenza, Human | Phase 2 | United States | 31 Jan 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free